Perspective Therapeutics Inc (CATX) PT Raised to $19 at Oppenheimer

Oppenheimer analyst Jeff Jones raised the price target on Perspective Therapeutics Inc (NYSE: CATX) to $19.00 (from $2.00) while maintaining a Outperform rating.

The analyst commented: "On Monday morning, CATX began trading on a 10-for-1 reverse split basis. We adjust our PT reflecting consolidation of shares, and incorporate the impact of the $80M financing announced in May. Maintain Outperform, PT to $19."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'